{"id":"https://openalex.org/W4391362789","doi":"https://doi.org/10.3390/ph17020182","title":"Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug\u2013Drug Interaction Study","display_name":"Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug\u2013Drug Interaction Study","publication_year":2024,"publication_date":"2024-01-30","ids":{"openalex":"https://openalex.org/W4391362789","doi":"https://doi.org/10.3390/ph17020182","pmid":"https://pubmed.ncbi.nlm.nih.gov/38399397","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10892269"},"language":"en","primary_location":{"id":"doi:10.3390/ph17020182","doi":"https://doi.org/10.3390/ph17020182","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph17020182","pdf_url":"https://www.mdpi.com/1424-8247/17/2/182/pdf?version=1706619769","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1424-8247/17/2/182/pdf?version=1706619769","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070663284","display_name":"Irene Moreno","orcid":"https://orcid.org/0000-0001-5027-6388","observed_orcids":["https://orcid.org/0000-0001-5027-6388"]},"institutions":[{"id":"https://openalex.org/I4210137474","display_name":"Hospital Universitario HM Sanchinarro","ror":"https://ror.org/04jep6391","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122338","https://openalex.org/I4210137474"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Irene Moreno","raw_affiliation_strings":["START Madrid\u2014CIOCC, Centro Integral Oncol\u00f3gico Clara Campal, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0001-5027-6388","affiliations":[{"raw_affiliation_string":"START Madrid\u2014CIOCC, Centro Integral Oncol\u00f3gico Clara Campal, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain","institution_ids":["https://openalex.org/I4210137474"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056008207","display_name":"Tatiana Hern\u00e1ndez\u2010Guerrero","orcid":"https://orcid.org/0000-0003-3459-871X","observed_orcids":["https://orcid.org/0000-0003-3459-871X"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Tatiana Hern\u00e1ndez","raw_affiliation_strings":["START Madrid\u2014FJD, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0003-3459-871X","affiliations":[{"raw_affiliation_string":"START Madrid\u2014FJD, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain","institution_ids":["https://openalex.org/I4210129357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053069942","display_name":"Emiliano Calvo","orcid":"https://orcid.org/0000-0003-4921-829X","observed_orcids":["https://orcid.org/0000-0003-4921-829X"]},"institutions":[{"id":"https://openalex.org/I4210137474","display_name":"Hospital Universitario HM Sanchinarro","ror":"https://ror.org/04jep6391","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210122338","https://openalex.org/I4210137474"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Emiliano Calvo","raw_affiliation_strings":["START Madrid\u2014CIOCC, Centro Integral Oncol\u00f3gico Clara Campal, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0003-4921-829X","affiliations":[{"raw_affiliation_string":"START Madrid\u2014CIOCC, Centro Integral Oncol\u00f3gico Clara Campal, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain","institution_ids":["https://openalex.org/I4210137474"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030621386","display_name":"Salvador Fudio","orcid":"https://orcid.org/0000-0001-7320-6139","observed_orcids":["https://orcid.org/0000-0001-7320-6139"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Salvador Fudio","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":"https://orcid.org/0000-0001-7320-6139","affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048766168","display_name":"Carmen Maria Kahatt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen Kahatt","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cristian Fern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristian Fern\u00e1ndez","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090502232","display_name":"Jorge Luis Iglesias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jorge Luis Iglesias","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gema Corral","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gema Corral","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016698105","display_name":"Laura P\u00e9rez\u2010Ramos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura P\u00e9rez-Ramos","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069604861","display_name":"Lola Montilla","orcid":"https://orcid.org/0000-0003-0312-8686","observed_orcids":["https://orcid.org/0000-0003-0312-8686"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Lola Montilla","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083698345","display_name":"Ali Hassan Zeaiter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ali Zeaiter","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036714492","display_name":"Rubin Lubomirov","orcid":"https://orcid.org/0000-0003-0550-8228","observed_orcids":["https://orcid.org/0000-0003-0550-8228"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Rubin Lubomirov","raw_affiliation_strings":["PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaMar S.A., Colmenar Viejo, 28770 Madrid, Spain","institution_ids":["https://openalex.org/I4210116403"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5036714492"],"corresponding_institution_ids":["https://openalex.org/I4210116403"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3296},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3296},"fwci":0.6944,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.60128453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"17","issue":"2","first_page":"182","last_page":"182"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lurbinectedin","display_name":"lurbinectedin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bosentan","display_name":"bosentan","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9200000166893005},{"id":"https://openalex.org/keywords/cyp3a4-induction","display_name":"CYP3A4 induction","score":0.9639999866485596},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9879999756813049},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.3959999978542328},{"id":"https://openalex.org/keywords/unbound-plasma-concentration","display_name":"unbound plasma concentration","score":0.5929999947547913},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7813897728919983},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6701914668083191},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.6481075286865234},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6437265872955322},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6319583654403687},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.5747278928756714},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5304030179977417},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5090996623039246},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4674089252948761},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.4280414581298828},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.42248788475990295},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25170642137527466},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06399166584014893},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/ph17020182","doi":"https://doi.org/10.3390/ph17020182","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph17020182","pdf_url":"https://www.mdpi.com/1424-8247/17/2/182/pdf?version=1706619769","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10892269","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10892269","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10892269/pdf/pharmaceuticals-17-00182.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals (Basel)","raw_type":"Text"},{"id":"pmid:38399397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38399397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2f75e678357d40b39912b602ad6fea06","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2f75e678357d40b39912b602ad6fea06","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceuticals, Vol 17, Iss 2, p 182 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/ph17020182","doi":"https://doi.org/10.3390/ph17020182","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph17020182","pdf_url":"https://www.mdpi.com/1424-8247/17/2/182/pdf?version=1706619769","source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320327811","display_name":"PharmaMar","ror":"https://ror.org/02h694m69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391362789.pdf","grobid_xml":"https://content.openalex.org/works/W4391362789.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1603105736","https://openalex.org/W1880352874","https://openalex.org/W1910386836","https://openalex.org/W1966062901","https://openalex.org/W1969159353","https://openalex.org/W2130862071","https://openalex.org/W2518722917","https://openalex.org/W2529120334","https://openalex.org/W2579529229","https://openalex.org/W3013383466","https://openalex.org/W3063858912","https://openalex.org/W3111498065","https://openalex.org/W3155388144","https://openalex.org/W3199788287","https://openalex.org/W4205409567","https://openalex.org/W4225141893","https://openalex.org/W4284988128","https://openalex.org/W4291994076","https://openalex.org/W4293375172","https://openalex.org/W4361266898","https://openalex.org/W4379339451","https://openalex.org/W4385296543","https://openalex.org/W4385683594"],"related_works":["https://openalex.org/W4394880618","https://openalex.org/W4387811541","https://openalex.org/W1989798818","https://openalex.org/W2023961603","https://openalex.org/W2528058754","https://openalex.org/W2021218460","https://openalex.org/W1592629354","https://openalex.org/W1541154061","https://openalex.org/W1975322245","https://openalex.org/W2328786092"],"abstract_inverted_index":{"This":[0],"open-label,":[1],"two-way,":[2],"crossover,":[3],"phase":[4],"Ib":[5],"drug\u2013drug":[6],"interaction":[7],"study":[8],"investigated":[9],"whether":[10],"the":[11,112,118,143,151,173,196,199],"pharmacokinetics":[12],"(PKs)":[13],"and":[14,53,67,73,127,131,191,213],"safety":[15,168,215],"profile":[16,169],"of":[17,24,121,153,184,198,207],"lurbinectedin":[18],"(LRB)":[19],"are":[20],"affected":[21],"by":[22,123,134],"co-administration":[23,209],"a":[25,203],"moderate":[26],"CYP3A4":[27],"inducer":[28],"(bosentan,":[29],"BOS)":[30],"in":[31,49,56,65,71,182],"adult":[32],"patients":[33,39,76],"with":[34,98,109,137,159,172,190],"advanced":[35],"solid":[36],"tumors.":[37],"Eleven":[38],"were":[40,80,186],"randomly":[41],"assigned":[42],"to":[43,155],"Sequence":[44,61],"1":[45,51,89],"(LRB":[46,63],"+":[47,69],"BOS":[48,70,100,110,138,149,208],"Cycle":[50,57],"[C1]":[52],"LRB":[54,68,86,122,146,154,167,189,211],"alone":[55,64,95],"2":[58,62],"[C2])":[59],"or":[60,96],"C1":[66],"C2),":[72],"finally,":[74],"eight":[75],"(four":[77],"per":[78],"sequence)":[79],"considered":[81],"evaluable":[82],"for":[83,125,129,177],"PK":[84,147],"assessment.":[85],"(3.2":[87],"mg/m2,":[88],"h":[90,104],"[h],":[91],"intravenous)":[92],"was":[93,170],"administered":[94],"combined":[97],"multiple":[99],"administration":[101],"(125":[102],"mg/12":[103],"oral;":[105],"5.5":[106],"days).":[107],"Co-administration":[108,136],"decreased":[111],"systemic":[113],"total":[114],"exposure":[115,212],"(area":[116],"under":[117],"curve,":[119],"AUC)":[120],"21%":[124],"AUC0\u2013t":[126],"20%":[128],"AUC0\u2013\u221e":[130],"increased":[132,150],"clearance":[133],"25%.":[135],"did":[139],"not":[140],"significantly":[141],"modify":[142],"unbound":[144],"plasma":[145],"parameters.":[148],"conversion":[152],"its":[156,163,214],"metabolite":[157,164],"M1,":[158],"no":[160],"changes":[161,201],"on":[162,210],"M4.":[165],"The":[166],"consistent":[171],"toxicities":[174],"previously":[175],"described":[176],"this":[178],"drug.":[179],"No":[180],"differences":[181],"terms":[183],"toxicity":[185],"found":[187],"between":[188],"without":[192],"BOS.":[193],"In":[194],"summary,":[195],"magnitude":[197],"observed":[200],"precludes":[202],"clinically":[204],"relevant":[205],"effect":[206],"profile.":[216]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-01-31T00:00:00"}